Derivation of human embryonic stem cells with NEMO deficiency

Stem Cell Res. 2012 May;8(3):410-5. doi: 10.1016/j.scr.2011.12.007. Epub 2012 Jan 4.

Abstract

Deficiency of the nuclear factor-kappa-B essential modulator (NEMO) is a rare X-linked disorder that presents in boys as hypohydrotic ectodermal dysplasia with immunodeficiency due to defective nuclear factor-κB activation. Here we report on the generation of 2 human embryonic stem cell lines from discarded in vitro fertilization (IVF) embryos ascertained via preimplantation genetic diagnosis. We have derived two human embryonic stem cell lines that carry a T458G hypomorphic mutation in exon 4 of the NEMO (or IKBKG) gene. One of the lines is diploid male; the other is diploid female but has clonally inactivated the X-chromosome that harbors the wild-type IKBKG gene. We show that both lines are pluripotent, have the capacity to differentiate into hematopoietic progenitors, and have defective inhibitor of nuclear factor kappa-B kinase activity. These NEMO deficiency hES cell lines provide an unlimited source for differentiated cell types and may serve as a unique tool to study NEMO deficiency and potentially lead to the development of new therapies for this disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles
  • Amino Acid Substitution
  • Animals
  • Cells, Cultured
  • Chromosomes, Human, X / genetics
  • Embryonic Stem Cells / cytology
  • Embryonic Stem Cells / drug effects
  • Embryonic Stem Cells / metabolism*
  • Exons
  • Female
  • Humans
  • I-kappa B Kinase / deficiency*
  • I-kappa B Kinase / genetics*
  • I-kappa B Kinase / metabolism*
  • Karyotyping
  • Male
  • Mice
  • Mutation
  • NF-kappa B / metabolism
  • Tumor Necrosis Factor-alpha / pharmacology

Substances

  • IKBKG protein, human
  • NF-kappa B
  • Tumor Necrosis Factor-alpha
  • I-kappa B Kinase